HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroya Takeuchi Selected Research

Colorectal Neoplasms (Colorectal Cancer)

3/2024Long-term prognosis after stapled and hand-sewn ileal pouch-anal anastomoses for familial adenomatous polyposis: a multicenter retrospective study.
2/2023Prevention of ureteral injury during laparoscopic colorectal cancer surgery with horseshoe kidney using fluorescent ureteral catheters: a case report.
7/2022Saturated Fatty Acids in Cell Membrane Lipids Induce Resistance to 5-Fluorouracil in Colorectal Cancer Cells.
1/2019Highly sensitive diagnostic method for colorectal cancer using the ratio of free DNA fragments in serum.
11/2005X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling.
4/2005Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
4/2003c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroya Takeuchi Research Topics

Disease

90Neoplasms (Cancer)
03/2024 - 01/2003
85Esophageal Neoplasms (Esophageal Cancer)
04/2024 - 07/2007
47Esophageal Squamous Cell Carcinoma
03/2024 - 08/2003
44Stomach Neoplasms (Stomach Cancer)
04/2024 - 03/2008
33Neoplasm Metastasis (Metastasis)
09/2023 - 01/2003
16Lymphatic Metastasis
11/2023 - 08/2003
13Melanoma (Melanoma, Malignant)
07/2020 - 01/2003
12Adenocarcinoma
11/2023 - 12/2012
11Pneumonia (Pneumonitis)
07/2023 - 05/2015
10Carcinoma (Carcinomatosis)
01/2022 - 04/2003
9Anastomotic Leak
07/2023 - 03/2014
8Inflammation (Inflammations)
01/2024 - 05/2010
7Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 04/2003
6Hemorrhage
11/2023 - 03/2004
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2023 - 09/2010
5Residual Neoplasm
06/2023 - 05/2019
5Gastrointestinal Neoplasms (Gastrointestinal Cancer)
06/2022 - 11/2008
5Acute Lung Injury
09/2017 - 05/2010
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2016 - 08/2003
4Adenoma (Adenomas)
03/2024 - 10/2004
4Rectal Neoplasms (Rectal Cancer)
03/2024 - 12/2012
4Carcinogenesis
10/2021 - 07/2013
4Disease Progression
01/2021 - 01/2018
4Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
09/2015 - 05/2010
4Sepsis (Septicemia)
01/2014 - 05/2010
3Endoleak
01/2023 - 01/2019
3Lymphedema (Milroy Disease)
01/2023 - 01/2020
3Chylothorax
11/2020 - 02/2013
3Weight Loss (Weight Reduction)
01/2020 - 08/2014
3Neoplasm Micrometastasis
07/2019 - 10/2003
3Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2018 - 04/2012
3Emergence Delirium
01/2018 - 11/2012
2Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
03/2024 - 05/2022
2Lung Neoplasms (Lung Cancer)
01/2024 - 01/2019

Drug/Important Bio-Agent (IBA)

12Messenger RNA (mRNA)IBA
01/2023 - 01/2003
11CytokinesIBA
01/2024 - 07/2010
11Cisplatin (Platino)FDA LinkGeneric
07/2023 - 09/2010
10Coloring Agents (Dyes)IBA
01/2018 - 10/2003
8Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2023 - 01/2013
7C-Reactive ProteinIBA
11/2023 - 01/2015
7Fibrinogen (Factor I)FDA Link
10/2022 - 12/2007
7Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2003
7Colloids (Colloid)IBA
01/2018 - 01/2013
7RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2011 - 01/2003
6Biomarkers (Surrogate Marker)IBA
01/2024 - 06/2009
6ParaffinIBA
08/2015 - 10/2003
6AntigensIBA
09/2012 - 01/2003
5Interleukin-8 (Interleukin 8)IBA
01/2024 - 04/2015
5Docetaxel (Taxotere)FDA Link
01/2024 - 07/2018
5SolutionsIBA
01/2023 - 09/2014
5HMGB1 Protein (HMG1)IBA
04/2015 - 05/2010
4Immune Checkpoint InhibitorsIBA
03/2024 - 06/2022
4Indicators and Reagents (Reagents)IBA
02/2024 - 01/2015
4Interleukin-6 (Interleukin 6)IBA
01/2024 - 03/2013
4Fluorouracil (Carac)FDA LinkGeneric
11/2023 - 01/2019
4NivolumabIBA
10/2022 - 07/2020
4AlbuminsIBA
02/2021 - 01/2015
4Chemokine ReceptorsIBA
03/2008 - 04/2004
3EnzymesIBA
04/2024 - 04/2015
3Therapeutic UsesIBA
04/2023 - 01/2023
3TenascinIBA
01/2023 - 01/2019
3Fatty Acids (Saturated Fatty Acids)IBA
07/2022 - 04/2018
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2019 - 04/2003
3SodiumIBA
10/2018 - 05/2010
3InterferonsIBA
07/2018 - 06/2009
3Imatinib Mesylate (Gleevec)FDA Link
01/2018 - 07/2013
3TinIBA
01/2018 - 09/2014
3Serum AlbuminIBA
06/2017 - 01/2015
3Eosine Yellowish-(YS) (Eosin)IBA
10/2013 - 01/2010
3Hematoxylin (Haematoxylon)IBA
10/2013 - 01/2010
3sivelestatIBA
09/2013 - 05/2010
3Secretory Proteinase Inhibitory ProteinsIBA
09/2013 - 05/2010
3MART-1 AntigenIBA
11/2005 - 01/2003

Therapy/Procedure

70Esophagectomy
02/2024 - 11/2007
33Gastrectomy
04/2024 - 03/2008
33Neoadjuvant Therapy
02/2024 - 09/2011
33Lymph Node Excision (Lymph Node Dissection)
09/2022 - 10/2003
25Therapeutics
01/2024 - 07/2007
25Drug Therapy (Chemotherapy)
11/2023 - 03/2004
23Chemoradiotherapy
02/2024 - 08/2003
9Operative Surgical Procedures
01/2022 - 07/2010
7Radiotherapy
10/2023 - 03/2004
6Minimally Invasive Surgical Procedures
01/2020 - 11/2011
5Enteral Nutrition (Feeding, Tube)
11/2023 - 05/2015
5Immunotherapy
12/2021 - 01/2003
4Restorative Proctocolectomy
03/2024 - 06/2020
4Pancreaticoduodenectomy
11/2023 - 01/2019
4Colectomy
03/2023 - 09/2021
4Laparotomy
06/2021 - 03/2004
4Combination Drug Therapy (Combination Chemotherapy)
04/2020 - 09/2010
4Punctures
01/2014 - 05/2010
4Ligation
01/2014 - 05/2010
3Catheters
09/2023 - 05/2018
3Endovascular Aneurysm Repair
01/2023 - 01/2019
3Pancreatectomy
12/2022 - 05/2020
3Salvage Therapy
11/2022 - 10/2020
3Stents
11/2021 - 01/2020
3Cytoreduction Surgical Procedures
01/2018 - 01/2003
3Transplantation
01/2018 - 06/2014
2Aftercare (After-Treatment)
02/2024 - 03/2005